Spanish drive to promote prostate screening
This article was originally published in Clinica
Executive Summary
All Spanish men aged between 50 and 75 years should undergo annual prostate screening - based on the prostate-specific antigen (PSA) test and manual rectal examination - to reduce the incidence of the disease. All suspect cases should then be followed up with a transrectal ultrasound and a biopsy to confirm the diagnosis. So says the Spanish urology association (AEU) in a position paper that calls for better information to be made available on the importance of early detection of the disease through regular screening.
You may also be interested in...
Xbrane Assembles The Troops As FDA Says No To Lucentis Biosimilar
Xbrane Biopharma was riding the crest of a wave with the EU launch of its biosimilar to Lucentis, following years of toil and investment. However, plans to roll out the product in the US will have to be pushed back – likely – into the middle of 2025, following a US FDA complete response letter.
UK MHRA Updates Assistive Tech And Borderline Regulations
Device classification themes were uppermost in April for the UK regulator, which issued key guidance in two areas prone to complexities. It also contributed to the MedTech Directorate’s one-year progress report.
Fujifilm Demonstrates Health Specialism With European HealthTech Spinout
From X-ray film in 1936 to the world’s first digital X-ray system in 1983, Fujifilm has a long heritage in medical diagnostics.